Association between non-malignant monoclonal gammopathy and adverse outcomes in chronic kidney disease: A cohort study.
Anthony FentonRajkumar ChinnaduraiVenkata R Latha GullapudiPetros KampanisIndranil DasguptaJames RitchieStephen HardingCharles Joseph FerroPhilip A KalraMaarten W TaalPaul CockwellPublished in: PLoS medicine (2020)
The prevalence of MG was higher in this CKD cohort than that reported in the general population. However, the presence of an MG was not independently associated with a significantly higher risk of kidney failure or, unlike in the general population, risk of death.
Keyphrases